Fasting Blood Glucose at Admission Predicts Mortality in Patients With COVID-19 Without Previous Diagnosis of Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fasting Blood Glucose at Admission Is an Independent Predictor for 28-Day Mortality in Patients With COVID-19 Without Previous Diagnosis of Diabetes: A Multi-Centre Retrospective Study
Diabetologia 2020 Oct 01;63(10)2102-2111, S Wang, P Ma, S Zhang, S Song, Z Wang, Y Ma, J Xu, F Wu, L Duan, Z Yin, H Luo, N Xiong, M Xu, T Zeng, Y JinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.